John B. Liao, Ph.D.
Affiliations: | Yale University, New Haven, CT |
Area:
Molecular Biology of Tumor VirusesGoogle:
"John Liao"Mean distance: 9.62 | S | N | B | C | P |
Parents
Sign in to add mentor| Daniel C. DiMaio | grad student | 2007 | Yale | |
| (Studies of therapeutic vaccination and immune evasion by human papillomavirus oncoproteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Disis ML, Adams SF, Bajpai J, et al. (2023) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal For Immunotherapy of Cancer. 11 |
| Cecil DL, Liao JB, Dang Y, et al. (2021) Immunization with a plasmid DNA vaccine encoding the N-terminus of Insulin like Growth Factor Binding Protein-2 in advanced ovarian cancer leads to high level Type I immune responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Morse CB, Toukatly MN, Kilgore MR, et al. (2019) Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma. Gynecologic Oncology |
| Liao JB, Fisher CE, Madeleine MM. (2019) Gynecologic cancers and solid organ transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons |
| Liao JB, Gwin WR, Urban R, et al. (2019) Pembrolizumab with low dose carboplatin for recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer-interim results. Journal of Clinical Oncology. 37: 5519-5519 |
| Gwin WR, Childs J, Higgins D, et al. (2018) Phase II study of neoadjuvant IGFBP-2 vaccination with neoadjuvant carboplatin and paclitaxel in advanced ovarian cancer. Journal of Clinical Oncology. 36 |
| Johnson N, Liao JB. (2017) Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society |
| Goff BA, Agnew K, Neradilek MB, et al. (2017) Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecologic Oncology |
| Morse CB, Elvin JA, Gay LM, et al. (2017) Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer. Gynecologic Oncology Reports. 21: 78-80 |
| Liao JB, Swensen RE, Ovenell KJ, et al. (2017) Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer. Gynecologic Oncology |